Gilead Sciences GILD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $7.56B-24.3% | $9.99B+64.2% | $6.09B+12.4% | $5.41B+1.4% | ||
| $68M— | $0-100% | $1.18B+21.2% | $973M-17.7% | ||
| $5.9B+10.8% | $5.32B-3.2% | $5.5B+0.6% | $5.46B+3.5% | ||
| $2.59B+38.1% | $1.88B+19.1% | $1.58B+20.2% | $1.31B+17.7% | ||
| $18.34B-4.3% | $19.17B+19.2% | $16.09B+11.4% | $14.44B-2.2% | ||
| $5.61B+3.5% | $5.41B+1.8% | $5.32B-2.9% | $5.48B+6.9% | ||
| $8.31B0.0% | $8.31B0.0% | $8.31B0.0% | $8.31B-0.2% | ||
| $59.02B0.0% | $59B-5.0% | $62.13B-1.7% | $63.17B-7.0% | ||
| $715M-14.2% | $833M+51.5% | $550M-39.2% | $905M+28.4% | ||
| $2.81B+54.7% | $1.82B+0.9% | $1.8B-20.9% | $2.27B+49.9% | ||
| $11.81B-1.6% | $12B+6.4% | $11.28B+0.4% | $11.24B-3.2% | ||
| $22.13B-11.1% | $24.9B+7.4% | $23.19B+1.0% | $22.96B-8.8% | ||
| $13.73B+19.4% | $11.5B-29.5% | $16.3B+3.9% | $15.69B-3.9% | ||
| $22.7B+17.4% | $19.33B-15.3% | $22.83B+7.5% | $21.24B+0.8% | ||
| $59.02B0.0% | $59B-5.0% | $62.13B-1.7% | $63.17B-7.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Gilead Sciences's total assets?
- Gilead Sciences (GILD) holds $56.3B in total assets, down 0.3% year over year.
- How much debt does Gilead Sciences have?
- Gilead Sciences carries $22.2B in total debt against $23.5B of shareholders' equity, a debt-to-equity ratio of 0.94.
- How much cash does Gilead Sciences have?
- Gilead Sciences holds $7.6B in cash and equivalents.
- Can Gilead Sciences cover its short-term obligations?
- Its current ratio is 1.97 — current assets exceed current liabilities.
- Where does Gilead Sciences's balance sheet data come from?
- Every line is extracted from Gilead Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
